Ho P C, Wong L C, Lawton J W, Ma H K
Arch Gynecol. 1984;234(4):255-61. doi: 10.1007/BF02113810.
The total blood lymphocyte counts, T-cell counts, B-cell counts, percentage of T cells bearing Fc receptors for IgG (TG), lymphocyte responses to phytohaemagglutinin and concanavalin A and serum IgA levels were measured in 15 patients with hydatidiform mole, 32 patients with malignant trophoblastic disease, 30 pregnant controls, and 34 normal non-pregnant controls. The mean percentage of TG was similar in all four groups but the mean absolute number of TG in patients with malignant trophoblastic disease was significantly lower than that in normal non-pregnant controls, due to the lower mean lymphocyte count and T-cell count in the former group. An immune profile score based on the T-cell count, B-cell count, lymphocyte response to mitogens, and serum IgA level was useful in predicting the subsequent development of malignant trophoblastic disease in patients with hydatidiform mole but was not helpful in predicting resistance to chemotherapy in malignant trophoblastic disease.
对15例葡萄胎患者、32例恶性滋养细胞疾病患者、30例妊娠对照组及34例正常非妊娠对照组进行了全血淋巴细胞计数、T细胞计数、B细胞计数、携带IgG Fc受体的T细胞百分比(TG)、淋巴细胞对植物血凝素和刀豆球蛋白A的反应以及血清IgA水平的检测。四组中TG的平均百分比相似,但恶性滋养细胞疾病患者TG的平均绝对数显著低于正常非妊娠对照组,原因是前一组的平均淋巴细胞计数和T细胞计数较低。基于T细胞计数、B细胞计数、淋巴细胞对有丝分裂原的反应以及血清IgA水平的免疫谱评分有助于预测葡萄胎患者随后发生恶性滋养细胞疾病,但对预测恶性滋养细胞疾病的化疗耐药性并无帮助。